Rodabe Amaria

Rodabe Amaria

UNVERIFIED PROFILE

Are you Rodabe Amaria?   Register this Author

Register author
Rodabe Amaria

Rodabe Amaria

Publications by authors named "Rodabe Amaria"

Are you Rodabe Amaria?   Register this Author

52Publications

2169Reads

30Profile Views

Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade.

Int J Dermatol 2019 Sep 20;58(9):1045-1052. Epub 2017 Nov 20.

Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.13833DOI Listing
September 2019

Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.

Am J Manag Care 2019 Feb;25(2 Spec No.):SP43-SP44

View Article

Download full-text PDF

Source
February 2019

Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials.

Ther Adv Med Oncol 2019 19;11:1758835919830826. Epub 2019 Feb 19.

The University of Texas MD Anderson Cancer Center, Department of Melanoma Medical Oncology, 1515 Holcombe Boulevard, Unit 0430, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758835919830826
Publisher Site
http://dx.doi.org/10.1177/1758835919830826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384439PMC
February 2019

TIL therapy and anti-CTLA4: can they co-exist?

Oncotarget 2019 Jan 1;10(1):1-2. Epub 2019 Jan 1.

Chantale Bernatchez: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26509
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343756PMC
January 2019

Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.

Cancer Treat Rev 2018 Nov 29;70:144-153. Epub 2018 Aug 29.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77040, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.011DOI Listing
November 2018

Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.

Am J Clin Dermatol 2018 Oct;19(5):639-646

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, 1500 Holcombe Boulevard, Houston, TX, 77004, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-018-0371-8DOI Listing
October 2018

Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.

Melanoma Res 2017 12;27(6):580-584

Departments of aMelanoma Medical Oncology bDiagnostic Radiology cRadiation Oncology dNeurosurgery, The University of Texas MD Anderson Cancer eRadiation Oncology, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000389DOI Listing
December 2017

Update on use of aldesleukin for treatment of high-risk metastatic melanoma.

Immunotargets Ther 2015 7;4:79-89. Epub 2015 Apr 7.

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/ITT.S61590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918260PMC
July 2016

Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.

Nucl Med Commun 2016 Feb;37(2):122-8

aDepartment of Radiology bDepartment of Medicine, Division of Medical Oncology, University of Colorado School of Medicine cDepartment of Biostatistics, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado dThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689629PMC
February 2016

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.

Cancer Biol Med 2014 Dec;11(4):237-46

1 Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA ; 2 Harvard Medical School, Boston, MA 02115, USA ; 3 Department of Melanoma Medical Oncology, 4 Department of Genomic Medicine, 5 Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296084PMC
December 2014

RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in Melanoma.

J Pigment Disord 2014 Nov 16;1(5). Epub 2014 Oct 16.

Division of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://omicsgroup.org/journals/raf-inhibitor-therapy-promote
Publisher Site
http://dx.doi.org/10.4172/2376-0427.1000139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731654PMC
November 2014

Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma.

Oncoimmunology 2014 Oct 13;3(9):e954956. Epub 2014 Dec 13.

Division of Surgical Oncology; The University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Genomic Medicine; The University of Texas MD Anderson Cancer Center ; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.954956DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292518PMC
October 2014

Dabrafenib for the treatment of melanoma.

Expert Opin Pharmacother 2014 May 10;15(7):1043-50. Epub 2014 Apr 10.

The University of Texas MD Anderson Cancer Center, Department of Melanoma Medical Oncology , Unit 430, 1515 Holcombe Blvd, Houston, TX 77030 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.909410DOI Listing
May 2014

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.

Cancer Immunol Immunother 2013 Nov 27;62(11):1711-22. Epub 2013 Sep 27.

Department of Surgery, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Academic Office One, Mailstop C313, 12631 E. 17th Ave, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1475-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176615PMC
November 2013

Novel therapies in melanoma.

Immunotherapy 2011 Dec;3(12):1461-9

Box B177, 1665 Aurora Court, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.11.136DOI Listing
December 2011

Therapeutic options in cutaneous melanoma: latest developments.

Ther Adv Med Oncol 2011 Sep;3(5):245-51

Department of Hematology/Oncology, University of Colorado at Denver, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834011415308
Publisher Site
http://dx.doi.org/10.1177/1758834011415308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169931PMC
September 2011

Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review.

Clin Breast Cancer 2008 Oct;8(5):449-52

Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152682091170543
Publisher Site
http://dx.doi.org/10.3816/CBC.2008.n.055DOI Listing
October 2008

Proprotein processing and pancreatic islet function.

Adv Exp Med Biol 2004 ;552:39-65

Barbara Davis Center for Childhood Diabetes, University of Colorado, Health Sciences Center, Denver, USA.

View Article

Download full-text PDF

Source
January 2005